Kewalramani Reshma
Vertex Pharmaceuticals Inc · CEO & President
Kewalramani Reshma is listed in filings as CEO & President at Vertex Pharmaceuticals Inc. This profile follows SEC Form 4 activity through Mar 3, 2026, including purchase activity and sale activity. Recent filings connect the profile to Vertex Pharmaceuticals Inc (VRTX) and Ginkgo Bioworks Holdings, Inc. (DNA). The current snapshot covers public activity from Jun 14, 2024 to Mar 3, 2026. Reported amounts are shown as $3.0M to $6.8M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.